Loss to Follow-Up: Patients with Type 1 Diabetes During the SARS-CoV-2 Pandemic.
Pediatr Ann
; 53(7): e254-e257, 2024 Jul.
Article
in En
| MEDLINE
| ID: mdl-38949871
ABSTRACT
The SARS-CoV-2 (severe acute respiratory syndrome related coronavirus 2) pandemic revealed many flaws in our health care system. This review aims to explore the significance of loss to follow-up on patients with type 1 diabetes during the pandemic, the morbidity and mortality associated, and strategies to prevent loss to follow-up or to re-engage patients in longitudinal care. [Pediatr Ann. 2024;53(7)e254-e257.].
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Diabetes Mellitus, Type 1
/
COVID-19
Limits:
Child
/
Humans
Language:
En
Journal:
Pediatr Ann
Year:
2024
Document type:
Article
Country of publication:
United States